Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.
Leuprolide Acetate 45 mg 6-Month Depot Formulation in Children With Central Precocious Puberty (CPP)
The purpose of this study is to determine the safety and effectiveness of a long acting medicine called leuprolide acetate (LA) 45 mg for the treatment of children with Central Precocious Puberty (CPP), a condition that causes children to show signs of puberty early.
About 40 boys and girls with precocious puberty, ages 2-11, will be in this study from 20 research centers in the United States and Puerto Rico. Up to 10 children will be enrolled at Nemours Children's Health in Jacksonville.
The study involves an initial screening visit; if your child is able to participate there will be up to 18 follow up visits which will last up to 36 months/144 weeks. You will have to come to the clinic every 1 to 2 months. Part 1 will last up to 12 months and Part 2 will last up to 24 months.
Your child will receive a total of 6 intramuscular injections of study medication (LA 45 mg formulation), 6 months apart:
A Leuprolide Acetate Stimulation Test will be done, at Screening and at Weeks 4, 12, 20, 24, 44, 48, 72, 96, 120, 144 and/or if your child exit the study early. A stimulation test is when a lower dose of LA is injected under the skin to test if your child has CPP or to check if the study medication is working. Blood samples will be taken three times (before the injection, and at 30 and 60 minutes after the injection). The study doctor may add a tiny needle under the skin to prevent multiple needle sticks to collect these blood samples.
Trial Name: Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2 Diabetes
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.